News Releases

Synlogic to Present at Jefferies 2017 Global Healthcare Conference

Synlogic and Mirna Investor Conference Call Replay

Synlogic and Mirna Investor Conference Call Information

Synlogic and Mirna Therapeutics Agree to Merger

Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting

Synlogic Appoints COO and Head of Corporate Development

Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia

Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic

Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation

Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors

Synlogic Secures $40 Million in Series B Financing

Synlogic Announces First Industry Collaboration to Develop a New Class of Medicines Designed to Power the Microbiome

Synlogic Therapeutics